Escalon Medical Corp. (ESMC) - Financial and Strategic SWOT Analysis Review by GlobalData

VIEWS: 28 PAGES: 39

Escalon Medical Corp. (Escalon) conducts the development, manufacturing, marketing and distribution of medical devices and pharmaceuticals in the fields of ophthalmology, diabetes, hematology and vascular access. The company operates through three business segments, namely, ECD, Sonomed-Escalon and Escalon Medical Corp. Through its ECD Business, the company develops and sells clinical diagnostic instruments, reagents and chemistries. Sonomed-Escalon segment consists of Sonomed, EMI and Trek, all of which conducts the development and sale of ophthalmic medical devices.

More Info
									        Escalon Medical Corp. (ESMC) - Financial and Strategic SWOT Analysis
                                       Review
        Reference Code: GDME309FSA                                                                                            Publication Date: MAR 2013

          435 Devon Park Drive, Building 100                 Phone              +1 610 6886830                  Revenue          24.5 (million USD)
          Wayne, PA                                          Fax                +1 610 6883641                  Net Profit       -5.94 (million USD)
          19087                                              Website            www.escalonmed.com              Employees        118
          United States                                      Exchange           ESMC [NASDAQ]                   Industry         Medical Equipment

       Company Overview
       Escalon Medical Corp. (Escalon) conducts the development, manufacturing, marketing and distribution of medical devices and
       pharmaceuticals in the fields of ophthalmology, diabetes, hematology and vascular access. The company operates through three
       business segments, namely, ECD, Sonomed-Escalon and Escalon Medical Corp. Through its ECD Business, the company
       develops and sells clinical diagnostic instruments, reagents and chemistries. Sonomed-Escalon segment consists of Sonomed,
       EMI and Trek, all of which conducts the development and sale of ophthalmic medical devices.
       Key Executives                                                                SWOT Analysis
                      Name                                 Title                      Escalon Medical Corp., SWOT Analysis
         Richard J. DePiano                  Chairman                                 Strengths                              Weaknesses
         Fred Choate                         Director
                                                                                      Strong Research and                    History of Operating Losses
         Anthony J. Coppola                  Director                                 Development Infrastructure
                                                                                                                             Limited Liquidity
         Jay L. Federman                     Director
                                                                                      In-House Manufacturing and
         William L.G. Kwan                   Director                                 Distribution Capability
        Source: Annual Report, Company Website, Primary and Secondary
        Research, GlobalData
                                                                                      Opportunities                          Threats
       Share Data
         Escalon Medical Corp.                                                        Strategic Divestitures                 Competitive Environment
        Share Price (USD) as on 15-Mar-                                  1.01         New Product Launches                   Stringent Government
        2013                                                                                                                 Regulations
        EPS (USD)                                                       -0.35
        Market Cap (million USD)                                            8        Source: Annual Report, Company Website, Primary and Secondary Research,
                                                                                     GlobalData
        Enterprise Value (million USD)                                     11
        Shares Outstanding (million)                                        8
       Source: Annual Report, Company Website, Primary and Secondary
       Research, GlobalData

       Financial Performance                                                         Recent Developments
                                                                                      Nov 09, 2012         Escalon     And    Modernizing      Announce
                                                                                                           Partnership For Offering Integrated EMR And
                                                                                                           Image Management
                                                                                      Sep 26, 2012         Escalon Medical Reports Revenue Of $24.4m
                                                                                                           In Fiscal 2012
                                                                                      May 15, 2012         Escalon Medical Reports Revenue Of $6.1m In
                                                                                                           Q3 Fiscal 2012
                                                                                      Feb 23, 2012         Sonomed Escalon Introduces VuMAX Auto
                                                                                                           Tracking Feature
       Source: Annual Report, Company Website, Primary and Secondary                 Source: Annual Report, Company Website, Primary and Secondary Research,
       Research, GlobalData                                                          GlobalData




Escalon Medical Corp. (ESMC) - Financial and Strategic SWOT                                                                       Reference Code: GDME309FSA
Analysis Review
Source : www.globalcompanyintelligence.com                                                                                                                     Page 1
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
       Table of Contents
       Table of Contents ............................................................................................................................................................................... 2
          List of Tables .................................................................................................................................................................................. 4
          List of Figures ................................................................................................................................................................................. 4
       Section 1 - About the Company.......................................................................................................................................................... 5
       Escalon Medical Corp. - Key Facts .................................................................................................................................................... 5
       Escalon Medical Corp. - Key Employees............................................................................................................................................ 6
       Escalon Medical Corp. - Key Employee Biographies ......................................................................................................................... 7
       Escalon Medical Corp. - Major Products and Services ....................................................................................................................... 8
       Escalon Medical Corp. - History ....................................................................................................................................................... 10
       Escalon Medical Corp. - Company Statement .................................................................................................................................. 12
       Escalon Medical Corp. - Locations And Subsidiaries ....................................................................................................................... 13
          Head Office ................................................................................................................................................................................... 13
          Other Locations & Subsidiaries ..................................................................................................................................................... 13
       Section 2 – Company Analysis ......................................................................................................................................................... 14
       Escalon Medical Corp. - Business Description ................................................................................................................................. 14
       Escalon Medical Corp. - Corporate Strategy .................................................................................................................................... 15
       Escalon Medical Corp. - SWOT Analysis ......................................................................................................................................... 16
          SWOT Analysis - Overview........................................................................................................................................................... 16
          Escalon Medical Corp. - Strengths ............................................................................................................................................... 16
             Strength - Strong Research and Development Infrastructure.................................................................................................... 16
             Strength - In-House Manufacturing and Distribution Capability ................................................................................................. 16
             Strength - Broad Patent Portfolio .............................................................................................................................................. 16
          Escalon Medical Corp. - Weaknesses .......................................................................................................................................... 16
             Weakness - History of Operating Losses .................................................................................................................................. 16
             Weakness - Limited Liquidity..................................................................................................................................................... 17
          Escalon Medical Corp. - Opportunities ......................................................................................................................................... 17
             Opportunity - Strategic Divestitures ........................................................................................................................................... 17
             Opportunity - New Product Launches........................................................................................................................................ 17
             Opportunity - Growing Markets of Ophthalmology Devices ....................................................................................................... 17
          Escalon Medical Corp. - Threats ................................................................................................................................................... 18
             Threat - Competitive Environment ............................................................................................................................................. 18
             Threat - Stringent Government Regulations .............................................................................................................................. 18
             Threat - Cost Containment Pressures ....................................................................................................................................... 18
             Threat - Rapid Technological Changes ..................................................................................................................................... 18
       Escalon Medical Corp. - Key Competitors ........................................................................................................................................ 19
       Section 3 – Company Financial Ratios ............................................................................................................................................. 20
       Financial Ratios - Capital Market Ratios........................................................................................................................................... 20
       Financial Ratios - Annual Ratios ...................................................................................................................................................... 20
       Performance Chart ........................................................................................................................................................................... 22
       Financial Performance...................................................................................................................................................................... 22
       Financial Ratios - Interim Ratios....................................................................................................................................................... 23
       Financial Ratios - Ratio Charts ......................................................................................................................................................... 24
       Section 4 – Company’s Lifesciences Financial Deals and Alliances ................................................................................................ 25
          Escalon Medical Corp., Medical Equipment, Deals By Year, 2007 to YTD 2013 .......................................................................... 25
          Escalon Medical Corp., Medical Equipment, Deals By Type, 2007 to YTD 2013 ......................................................................... 26


Escalon Medical Corp. (ESMC) - Financial and Strategic SWOT                                                                                                       Reference Code: GDME309FSA
Analysis Review
Source : www.globalcompanyintelligence.com                                                                                                                                                                Page 2
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
       Escalon Medical Corp., Recent Deals Summary .............................................................................................................................. 27
       Section 5 – Company’s Recent Developments ................................................................................................................................ 28
          Escalon Medical Corp., Recent Developments ............................................................................................................................. 28
             Nov 09, 2012: Escalon And Modernizing Announce Partnership For Offering Integrated EMR And Image Management ........ 28
             Sep 26, 2012: Escalon Medical Reports Revenue Of $24.4m In Fiscal 2012 ........................................................................... 28
             May 15, 2012: Escalon Medical Reports Revenue Of $6.1m In Q3 Fiscal 2012 ....................................................................... 29
             Feb 23, 2012: Sonomed Escalon Introduces VuMAX Auto Tracking Feature ........................................................................... 31
             Feb 23, 2012: Sonomed Escalon Announces Release Of AXIS iPad App ................................................................................ 31
             Feb 14, 2012: Escalon Medical Reports Revenue Of $6.3m In Q2 Fiscal 2012........................................................................ 32
             Jan 20, 2012: Escalon Subsidiary, Drew Announces That Its Subsidary BHH Has Initiated Filing Of An Insolvency Declaration
             In France ................................................................................................................................................................................... 33
       Section 6 – Appendix ....................................................................................................................................................................... 35
          Methodology ................................................................................................................................................................................. 35
          Ratio Definitions ............................................................................................................................................................................ 35
          About GlobalData ......................................................................................................................................................................... 39
          Contact Us .................................................................................................................................................................................... 39
          Disclaimer ..................................................................................................................................................................................... 39




Escalon Medical Corp. (ESMC) - Financial and Strategic SWOT                                                                                                       Reference Code: GDME309FSA
Analysis Review
Source : www.globalcompanyintelligence.com                                                                                                                                                                Page 3
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
       List of Tables
       Escalon Medical Corp., Key Facts...............................................................................................
								
To top